What this opportunity is
The National Cancer Institute (NCI) is seeking proposals for its Small Business Innovation Research (SBIR) Phase I Innovative Concept Award Program, focusing on innovative solutions to cancer-related challenges. This opportunity is a total small business set-aside, making it suitable for small businesses, including those that are 8(a), HubZone, Service-Disabled Veteran-Owned, Small Disadvantaged, or Woman-Owned. Interested firms should note that this is a solicitation notice, indicating they should prepare to submit proposals rather than simply track the opportunity.
Analysis by Mindy, grounded in the SAM.gov notice.
Description
DEPARTMENT OF HEALTH AND HUMAN SERVICES
SMALL BUSINESS INNOVATION RESEARCH PROGRAM
PHASE I CONCEPT AWARD TECHNICAL PROPOSAL SUBMISSION CHECKLIST
Complete Proposal Cover Sheet Page
Complete Abstract of the Research Plan and Public Health Relevance Page
Complete Technical Proposal Content
Complete Identification and Significance of the Problem or Opportunity Section
Complete Proposed Technological Solution Section
Optionally Attach 1-Page Preliminary Data/Figures Document
Complete Innovation Section
Complete Approach and Methodology Section
Complete Product Discovery and Development Section
Complete Potential Commercial Application Section
Complete Resources Section
Complete Authentication of Key Biological and/or Chemical Resources
Complete Scientific Data Sharing Plan Section
Complete References Section
Complete Statement of Work Pages
Attach Biosketches Document
-- 1 of 19 --
DEPARTMENT OF HEALTH AND HUMAN SERVICES
SMALL BUSINESS INNOVATION RESEARCH PROGRAM
PHASE I PROPOSAL COVER SHEET
TOPIC NO.:
PROJECT TITLE:
FAST TRACK PROPOSAL: YES NO
SUBMITTED BY (Firm name, address, and telephone number):
YEAR FIRM FOUNDED:
NO. OF EMPLOYEES (Include all affiliations):
NOTICE TO OFFERORS
The offeror organization and the principal investigator are jointly responsible for the accuracy and validity of all the administrative, fiscal, and
scientific information in the proposal. Deliberate withholding, falsification, or misrepresentation of information could result in a determination of non-
responsibility [see Federal Acquisition Regulation (FAR) 9.104] which would preclude an award to the offeror. In addition, sanctions such as
suspension, debarment, and criminal penalties could apply.
YES NO CERTIFICATIONS
1. The above organization certifies that it is a small business concern as defined in this Solicitation.
2. The above organization also certifies that it is one or more of the following small business concerns as defined in FAR 2.101:
8(a) HubZone Service-Disabled Veteran-Owned Small Disadvantaged Business Woman-Owned
* Note: Capture of this information is strictly for statistical purposes.
3. The above organization certifies that, if this proposal results in a contract award, more than one-half of the principal
investigator's time will be spent in the employ of the firm.
4. The above organization and / or principal investigator(s) have submitted contract proposals or grant applications for
essentially equivalent work (as defined in this Solicitation) under other federal programs, or have received other federal awards
containing a significant amount of essentially equivalent work. (If YES, include information required for “Prior, Current, or
Pending Support of Similar Proposals or Awards” in Appendix C – Pricing Proposal, as described in the solicitation.)
5. If this proposal does not result in an award, is the Government permitted to disclose the title and abstract of your research
project, and the name, address and telephone number of the corporate official of your firm, to organizations that may be
interested in contacting you for further information or possible investment?
6. This proposed project involves human subjects. (See instructions in Solicitation.)
Clinical Trial? Yes No
Agency-Defined Phase III Clinical Trial? Yes No
7. This proposed project involves vertebrate animals. (See instructions in Solicitation.) If YES, identify by common names and
circle primates.
NOTICE OF PROPRIETARY INFORMATION
The information identified by asterisks (*) on pages of this proposal constitutes trade secrets or information that is commercial or financial
and confidential or privileged. It is furnished to the Government in confidence with the understanding that such information shall be used or disclosed
only for evaluation of this proposal; provided that, if a contract is awarded as a result of or in connection with the submission of this proposal, the
Government shall have the right to use or disclose information herein to the extent provided by law. This restriction does not limit the Government’s
right to use the information if it is obtained without restriction from another source.
PRINCIPAL INVESTIGATOR/PROJECT MANAGER CORPORATE OFFICIAL
NAME: NAME:
SIGNATURE: SIGNATURE:
DATE: DATE:
TITLE: TITLE:
PHONE: PHONE:
E-MAIL ADDRESS: E-MAIL ADDRESS:
-- 2 of 19 --
ABSTRACT OF RESEARCH PLAN
NAME, ADDRESS, AND TELEPHONE NUMBER OF OFFEROR ORGANIZATION AGENCY NAME:
SOLICITATION NUMBER:
TOPIC NUMBER:
TITLE OF PROJECT
KEY PERSONNEL ENGAGED ON PROJECT
Name (First, Middle, Last) POSITION TITLE ORGANIZATION
ABSTRACT OR RESEARCH PLAN: State the proposal’s long-term objectives and specific aims, making reference to the health-relatedness of
the project. Describe concisely the research design and methods for achieving these goals, and discuss the potential of the research for
technological innovation. Summarize the results that are expected. Avoid summaries of past accomplishments and the use of the first person. This
abstract is meant to serve as a succinct and accurate description of the proposed work when separated from the application. If the proposal is
funded, this description, as is, will become public information. Therefore, do not include proprietary/confidential information. DO NOT EXCEED
200 WORDS.
Provide key words (8 maximum) to identify the research or technology.
Provide a brief summary of the potential commercial applications of the research.
-- 3 of 19 --
Technical Proposal Content
Technology/Product Overview ☐ Cell/Gene Therapy
☐ Drug Delivery Device
☐ Biologics/Vaccine
☐ Hospital Device
☐ Imaging Agent
☐ Bioinformatics/Health IT/Digital Health
☐ Small Molecule
☐ Surgical or Ablative Device
☐ Imaging Device
☐ In Vitro Diagnostic
☐ Research Tool
Targeted Pediatric/Rare Cancer (Please state the rare/pediatric cancer your technology addresses)
A) Identification and Significance of the Problem or Opportunity. Provide a clear statement of the specific technical problem or opportunit…
Source: SAM.gov, as posted. Verify the current solicitation before responding.